{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:47:30Z","timestamp":1761176850601,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.tracli.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T11:47:06Z","timestamp":1382960826000},"page":"458-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cartographie des risques a priori. S\u00e9curisation de la transfusion d\u2019un produit sanguin labile, dans un \u00e9tablissement de sant\u00e9\u00a0: de sa r\u00e9ception \u00e0 son administration"],"prefix":"10.1016","volume":"20","author":[{"given":"E.","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boyeldieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2013.09.001_bib0005","first-page":"141","article-title":"L\u2019analyse pr\u00e9liminaire des risques\u00a0: un outil adapt\u00e9 aux \u00e9tablissements de soins","volume":"III","author":"Desroches","year":"2006","journal-title":"Rev Risques Qual"},{"year":"2009","series-title":"L\u2019analyse pr\u00e9liminaire des risques","author":"Desroches","key":"10.1016\/j.tracli.2013.09.001_bib0010"},{"key":"10.1016\/j.tracli.2013.09.001_bib0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tracli.2013.02.002","article-title":"Le management des risques par l\u2019analyse globale des risques","volume":"20","author":"Desroches","year":"2013","journal-title":"Transfus Clin Biol"},{"year":"2006","series-title":"Pratique de l\u2019analyse fonctionnelle","author":"Tassinari","key":"10.1016\/j.tracli.2013.09.001_bib0020"},{"key":"10.1016\/j.tracli.2013.09.001_bib0025","unstructured":"Circulaire DGS\/DHOS\/AFSSAPS no\u00a003\/582\u00a0du 15\u00a0d\u00e9cembre 2003, relative \u00e0 la r\u00e9alisation de l\u2019acte transfusionnel."},{"year":"2013","series-title":"Cartographie des risques\u00a0: s\u00e9curisation de la transfusion d\u2019un produit sanguin labile\u00a0: de la r\u00e9ception \u00e0 son administration dans un service de soins","author":"Bertrand","key":"10.1016\/j.tracli.2013.09.001_bib0030"},{"key":"10.1016\/j.tracli.2013.09.001_bib0035","unstructured":"Arr\u00eat\u00e9 du 26\u00a0avril 2002, bonnes pratiques de laboratoire en immuno-h\u00e9matologie \u00e9rythrocytaire."},{"key":"10.1016\/j.tracli.2013.09.001_bib0040","unstructured":"Instruction no\u00a0DGOS\/MSIOS\/2013\/281\u00a0du 7\u00a0juin 2013, relative \u00e0 l\u2019utilisation du nom de famille (nom de naissance) pour l\u2019identification des patients."}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678201300503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678201300503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:34:10Z","timestamp":1761129250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S124678201300503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":8,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S124678201300503X"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2013.09.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cartographie des risques a priori. S\u00e9curisation de la transfusion d\u2019un produit sanguin labile, dans un \u00e9tablissement de sant\u00e9\u00a0: de sa r\u00e9ception \u00e0 son administration","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}